e-learning
resources
London 2016
Wednesday, 07.09.2016
Novel mechanisms and treatment modalities in asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Bronchial thermoplasty resulted in an increase of CD4+CD25+ regulatory T cells in severe asthma patients
Mateja Marc Malovrh (Kranj, Slovenia), Mateja Marc Malovrh, Aleš Rozman, Sabina Škrgat, Mira Šilar, Julij Šelb, Peter Korošec
Source:
International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Session:
Novel mechanisms and treatment modalities in asthma
Session type:
Poster Discussion
Number:
4906
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Mateja Marc Malovrh (Kranj, Slovenia), Mateja Marc Malovrh, Aleš Rozman, Sabina Škrgat, Mira Šilar, Julij Šelb, Peter Korošec. Bronchial thermoplasty resulted in an increase of CD4+CD25+ regulatory T cells in severe asthma patients. Eur Respir J 2016; 48: Suppl. 60, 4906
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Heterogeneous levels of CD86+CD209+ and CD83+CD209+ dendritic cells in patients with different severity of bronchial asthma
Source: Annual Congress 2013 –Genetics and mechanisms of, and tests for, allergy
Year: 2013
Bronchoscopic evaluation of the lower airways in patients with persistent severe asthma
Source: International Congress 2015 – Sedation and educational issues in bronchoscopy: basic bronchoscopic techniques
Year: 2015
The effect of bronchial thermoplasty on nerve C-fibers and inflammatory cells in patients with severe asthma
Source: International Congress 2015 – Bronchoscopic treatment of emphysema and asthma: what is new?
Year: 2015
Cost-effectiveness of bronchial thermoplasty (BT) treatment relative to no BT treatment option for patients with severe asthma
Source: International Congress 2014 – Asthma and COPD devices and treatments
Year: 2014
Peripheral blood Th9 cells and IL-9 level in asthma patients with early and dual asthmatic response
Source: International Congress 2015 – Novel mechanisms and treatments in allergy and asthma
Year: 2015
Peripheral blood Th17 / Treg ratio increases in late asthmatic response
Source: Annual Congress 2013 –Studies of asthma in man
Year: 2013
Expression of Th1, Th2 and Th17 cytokines in CD4
+
T cells in peripheral blood of asthma patients
Source: International Congress 2014 – Rationale behind respiratory drug development
Year: 2014
Characterisation of asthma patients with persistent airflow obstruction
Source: International Congress 2016 – Clinical studies in asthma and immunology
Year: 2016
Adult asthma patients reporting exacerbations triggered by upper airway infection have increased total IgE and sensitization to HDM
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014
Bronchial thermoplasty in patients with poorly controlled asthma: Three cases
Source: International Congress 2014 – New trends in bronchoscopy: EBUS-TBNA and endoscopic treatment of emphysema
Year: 2014
Airway basophils are increased and correlated with eosinophilic inflammtaion in asthma and COPD
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
Cytological and mRNAs peripheral blood markers of aspirin intolerance in asthmatics
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015
Using induced sputum cell counts to guide management of difficult-to-treat asthmatics
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013
Co-culture of naïve CD4+ T cells and vitamin D modulate – Th17 cells in young asthmatic children
Source: International Congress 2014 – Paediatric asthma: pathogenesis and immunology
Year: 2014
Association between Type 2 innate lymphoid cells increasement and allergy in patients with chronic rhinosinusitis and asthma
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016
Improved effects of aerosol-type fluticasone propionate/formoterol combination on residual asthmatic inflammation in distal airways of patients with moderate asthma
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014
Decreased regulation of lung CD8+ T cells by virally-infected macrophages in COPD: Role of PD1/PDL1 axis
Source: International Congress 2015 – Advances from translational research in respiratory infections
Year: 2015
Airway remodelling in the U-BIOPRED severe asthma cohort
Source: International Congress 2015 – Airway remodelling: recent developments
Year: 2015
Improved effects of formoterol-budesonide combination on residual eosinophilic inflammation in asthmatic peripheral airway
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013
TLR-3 triggered exacerbation of experimental asthma depends on IL-17 producing NK cells
Source: International Congress 2014 – TH17 and other acute asthmatic responses
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept